Trial Profile
Initial phase I pharmacokinetic trial of sublingual buprenorphine/naloxone (OX 219) compared with Suboxone(R).
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Sep 2011
Price :
$35
*
At a glance
- Drugs Buprenorphine/naloxone (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- 26 Sep 2011 New trial record